NY-BR-1 Protein Expression in Breast Carcinoma: A Mammary Gland Differentiation Antigen as Target for Cancer Immunotherapy

Cancer Immunology, Immunotherapy - Germany
doi 10.1007/s00262-007-0316-1
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

A Potential Role for Immunotherapy in Thyroid Cancer by Enhancing NY-ESO-1 Cancer Antigen Expression

Thyroid
MedicineEndocrinologyMetabolismDiabetes
2014English

Lewis Y Antigen as a Target for Breast Cancer Therapy

1996English

Ring Finger Protein 43 as a New Target for Cancer Immunotherapy

Clinical Cancer Research
Cancer ResearchOncology
2004English

NY-ESO-1 Cancer Testis Antigen Demonstrates High Immunogenicity in Triple Negative Breast Cancer

PLoS ONE
Multidisciplinary
2012English

Mesothelin, a Novel Immunotherapy Target for Triple Negative Breast Cancer

Breast Cancer Research and Treatment
Cancer ResearchOncology
2012English

Characterization of the Murine 5T4 Oncofoetal Antigen: A Target for Immunotherapy in Cancer

Biochemical Journal
BiochemistryCell BiologyMolecular Biology
2002English

ICAM-1 as a Molecular Target for Triple Negative Breast Cancer

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2014English

Mesothelin Expression in Advanced Gastroesophageal Cancer Represents a Novel Target for Immunotherapy

Applied Immunohistochemistry and Molecular Morphology
Forensic MedicinePathologyMedical Laboratory TechnologyHistology
2016English

ICOS-L as a Potential Therapeutic Target for Cancer Immunotherapy

Current Protein and Peptide Science
MedicineBiochemistryCell BiologyMolecular Biology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy